Johannes Gutenberg-Universität Mainz
- 6131/39-0
Labenz, Christian; Schattenberg, Joern M.; Woerns, Marcus-Alexander et al.
Response: Frailty assessment in the COVID-19 pandemicJOURNAL OF INVESTIGATIVE MEDICINE. Bd. 68. H. 7. 2020 S. 1302-1302
Breitenbach, Benjamin Bernhard
Responsive Polysaccharide Macrosurfactants from Dextran Building BlocksMainz: Univ. 2020 0 S.
Vosseler, Markus; El Shazly, Ahmed; Parker, John D. et al.
Resting and recruitable endothelial function - Evidence of two distinct circadian patternsCLINICAL HEMORHEOLOGY AND MICROCIRCULATION. Bd. 74. H. 2. 2020 S. 139-146
Babiloni, Claudio; Lopez, Susanna; Del Percio, Claudio et al.
Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer's neuropathology and high education level: the INSIGHT-preAD studyNEUROBIOLOGY OF AGING. Bd. 90. 2020 S. 43-59
Bell, Katharina; Beutgen, Vanessa M.; Nickels, Stefan et al.
Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion PatientsJOURNAL OF OPHTHALMOLOGY. Bd. 2020. 2020
Wiegel, Thomas; Albers, Peter; Bartkowiak, Detlef et al.
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2020
Heinrich, Stefan; Tripke, Verena; Huber, Tobias et al.
Results of multimodal treatment of hepatic echinococcosisCHIRURG. 2020
Musayeva, A.; Gericke, A.; Jaeger, F. et al.
Results of the Dry Eye Research Grant Award 2016OPHTHALMOLOGE. 2020
Scherer, Jonas; Whybra-Truempler, Catharina; Mildenberger, Eva
Results of the hypothermia registry of the University Hospital Dresden from 2010-2017. Application of hypothermia therapy in newborns in GermanyZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE. Bd. 224. H. 06. 2020 S. 367-373
Moehler, Markus H.; Dvorkin, Mikhail; Ozguroglu, Mustafa et al.
Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2-advanced gastric or gastroesophageal junction cancer (GC/GEJC)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020